Status:
UNKNOWN
Gene Mutations in Non-Small Cell Lung Cancer Cells
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Carcinoma, Non-Small-Cell Lung
Eligibility:
All Genders
20+ years
Brief Summary
To compare the frequency of individual genetic abnormality between tumor cells and blood specimens.
Detailed Description
Samples will be collected before the systemic therapy. After initiation of therapy, samples will be collected at end of the 1st month, at the end of the 2nd month at the end of 3rd months and once eve...
Eligibility Criteria
Inclusion
- Pathologic or cytological confirmation of NSCLC.
- Patients must understand and provide written informed consent prior to initiation of any study-specific procedures.
- Have a life expectancy 3 months.
- Have malignant pleural/pericardial effusion or metastatic non-small cell lung cancer.
- Have measurable or evaluable disease.
- ≥20 years.
- Candidate for systemic treatment such as EGFR-TKI or chemotherapy.
Exclusion
- Prior history of another malignancy (other than cured basal cell carcinoma of the skin or cured in-situ carcinoma of the cervix) within 5 years of study entry.
Key Trial Info
Start Date :
November 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2014
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00977509
Start Date
November 1 2009
End Date
December 1 2014
Last Update
December 2 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100